Generic placeholder image

Mini-Reviews in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1389-5575
ISSN (Online): 1875-5607

Biography

Meet the Editorial Board Member

Author(s): Imtiaz Ali Khan

Volume 23, Issue 16, 2023

Published on: 06 August, 2023

Page: [1591 - 1591] Pages: 1

DOI: 10.2174/138955752316230806171513

Price: $65

Next »
[1]
FLP-Catalyzed Transfer Hydrogenation of Silyl Enol Ethers. I. Khan, B. Reed-Berendt, R.L. Melen,* L.C. Morrill,* Angew. Chem. Int. Ed., 2018. Accepted.
[http://dx.doi.org/10.1002/anie.201808800R1]
[2]
Frustrated Lewis Pair (FLP)-Catalyzed Hydrogenation of Aza-Morita-Baylis-Hillman Adducts and Sequential Organo-FLP Catalysis. I. Khan, M. Manzotti, G.J. Tizzard, S.J. Coles, R.L. Melen,* L.C. Morrill,*. ACS Catal., 2017, 7, 7748-7752.
[3]
Enantioselective Synthesis of Spiroindenes by Enol-Directed Rh(III)-Catalyzed C–H Functionalization and Spiroannulation. S.R. Chidipudi, D.J. Burn, I. Khan; H.W. Lam,* Angew. Chem. Int. Ed. 2015, 54, 13975–13979; Angew. Chem. 2015, 127, 14181‒14185. [ChemInform abstract: 2016, 47 (12)] (Highlighted in Synfacts, 2016, 12, 161).
[4]
Synthesis of Spiroindanes by Palladium-Catalyzed Oxidative Annulations of Non- or Weakly Activated 1,3-Dienes Involving C–H Functionalization. I. Khan, S.R. Chidipudi, H.W. Lam,* Chem. Commun., 2015, 51, 2613-2616.
[5]
Synthesis of Benzopyrans by Pd(II) Or Ru(II)–Catalyzed Enolate–Directed C–H Alkenylation. S.R. Chidipudi, M.D. Wieczysty, I. Khan, H.W. Lam,*. Org. Lett., 2013, 15(3), 570-573. [ChemInform abstract: 2013, 44 (26)].
[6]
Functionalization of Csp3–H and Csp2–H Bonds: Synthesis of Spiroindenes by Enolate-Directed Ruthenium-Catalyzed Oxidative Annulation of Alkynes with 2-Aryl-1,3-dicarbonyl Compounds. S.R. Chidipudi, I. Khan, H.W. Lam,* Angew. Chem. Int. Ed. 2012, 51, 12115–12119. Angew. Chem., 2012, 124, 12281-12285. [ChemInform abstract: 2013, 44 (19)].
[7]
Quinolinic carboxylic acid derivatives as potential multi-target compounds for neurodegeneration: monoamine oxidase and cholinesterase inhibition. N.A. Khan,† I. Khan,† S.M.A. Abid, S. Zaib, A. Ibrar, H. Andleeb, S. Hameed,* J. Iqbal,* Med. Chem., 2018, 14, 74-85. (†equal contribution).
[8]
A new entry into the portfolio of α-glucosidase inhibitors as potent therapeutics for type 2 diabetes: design, bioevaluation and one-pot multi-component synthesis of diamine-bridged coumarinyl oxadiazole conjugates. M. Kazmi, S. Zaib, A. Ibrar, S.T. Amjad, Z. Shafique, S. Mehsud, A. Saeed, J. Iqbal, I. Khan,*. Bioorg. Chem., 2018, 77, 190-202.
[9]
Combined in Vitro and in Silico Studies for the Anticholinesterase Activity and Pharmacokinetics of Coumarinyl Thiazoles and Oxadiazoles. A. Ibrar, A. Khan, M. Ali, R. Sarwar, S. Mehsud, U. Farooq, S.M.A. Halimi, I. Khan*, A. Al-Harrasi,*. Front Chem., 2018, 6(61), 1-12.
[10]
2-Nitrobenzohydrazide as a Potent Urease Inhibitor: Synthesis, Characterization and Single Crystal X-ray Diffraction Analysis. N. Abbas, I. Khan, S. Batool, U. Farooq, A. Khan, Shahid Hameed,* J.M. White, A. Ibrar,* J. Pak. Chem. Soc, 2018, 40, 165-170.

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy